PMID- 38473032
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240315
IS  - 2075-4418 (Print)
IS  - 2075-4418 (Electronic)
IS  - 2075-4418 (Linking)
VI  - 14
IP  - 5
DP  - 2024 Mar 6
TI  - Clinical Evaluation of a New Spectral-Domain Optical Coherence Tomography-Based 
      Biometer.
LID - 10.3390/diagnostics14050560 [doi]
LID - 560
AB  - The VEMoS-AXL system is a new optical biometer based on spectral domain optical 
      coherence tomography (SD-OCT) that has been tested in terms of intrasession 
      repeatability and compared with a swept-source optical coherence tomography 
      biometer (SS-OCT), which is recognized as the gold standard for the performance 
      of an agreement analysis. A biometric analysis was performed three consecutive 
      times in 120 healthy eyes of 120 patients aged between 18 and 40 years with the 
      SD-OCT system, and afterwards, a single measurement was obtained with the SS-OCT 
      system. Within-subject standard deviations were 0.004 mm, 4.394 microm, and 0.017 mm 
      for axial length (AL), central corneal thickness (CCT), and anterior chamber 
      depth (ACD) measures obtained with the SD-OCT biometer, respectively. The 
      agreement between devices was good for AL (limits of agreement, LoA: -0.04 to 
      0.03 mm) and CCT (LoA: -4.36 to 14.38 microm), whereas differences between devices 
      were clinically relevant for ACD (LoA: 0.03 to 0.21 mm). In conclusion, the 
      VEMoS-AXL system provides consistent measures of anatomical parameters, being 
      most of them interchangeable with those provided by the SS-OCT-based gold 
      standard.
FAU - Alio, Jorge L
AU  - Alio JL
AD  - Research and Development Department, Vissum Grupo Miranza, 03016 Alicante, Spain.
AD  - School of Medicine, Miguel Hernandez University, 03202 Alicante, Spain.
FAU - Jose-Martinez, Marina
AU  - Jose-Martinez M
AD  - Research and Development Department, Vissum Grupo Miranza, 03016 Alicante, Spain.
FAU - Martinez-Abad, Antonio
AU  - Martinez-Abad A
AD  - Research and Development Department, Vissum Grupo Miranza, 03016 Alicante, Spain.
FAU - Rodriguez, Alejandra E
AU  - Rodriguez AE
AD  - Research and Development Department, Vissum Grupo Miranza, 03016 Alicante, Spain.
FAU - Versaci, Francesco
AU  - Versaci F
AD  - CSO (Construzioni Strumenti Oftalmici), 50018 Scandicci, Italy.
FAU - Hjortdal, Jesper
AU  - Hjortdal J
AD  - Department of Opthalmology, Aarhus University Hospital, 8000 Aarhus, Denmark.
FAU - Murta, Joaquim Neto
AU  - Murta JN
AD  - Department of Opthalmology, University of Coimbra, 3000-548 Coimbra, Portugal.
FAU - Plaza-Puche, Ana B
AU  - Plaza-Puche AB
AUID- ORCID: 0000-0001-5904-7530
AD  - Research and Development Department, Vissum Grupo Miranza, 03016 Alicante, Spain.
FAU - Canto-Cerdan, Mario
AU  - Canto-Cerdan M
AD  - Research and Development Department, Vissum Grupo Miranza, 03016 Alicante, Spain.
FAU - Pinero, David P
AU  - Pinero DP
AUID- ORCID: 0000-0002-1546-4807
AD  - Department of Optics, Pharmacology and Anatomy, University of Alicante, 03690 
      Alicante, Spain.
LA  - eng
GR  - 878748/European Union s Horizon 2020 research and innovation programme/
PT  - Journal Article
DEP - 20240306
PL  - Switzerland
TA  - Diagnostics (Basel)
JT  - Diagnostics (Basel, Switzerland)
JID - 101658402
PMC - PMC10931309
OTO - NOTNLM
OT  - anterior chamber depth
OT  - axial length
OT  - central corneal thickness
OT  - optical biometry
OT  - spectral-domain optical coherence tomography
OT  - swept-source optical coherence tomography
COIS- Francisco Versaci is employee of CSO. The rest of authors declare no conflicts of 
      interest.
EDAT- 2024/03/13 06:46
MHDA- 2024/03/13 06:47
PMCR- 2024/03/06
CRDT- 2024/03/13 01:17
PHST- 2023/12/18 00:00 [received]
PHST- 2024/02/28 00:00 [revised]
PHST- 2024/03/04 00:00 [accepted]
PHST- 2024/03/13 06:47 [medline]
PHST- 2024/03/13 06:46 [pubmed]
PHST- 2024/03/13 01:17 [entrez]
PHST- 2024/03/06 00:00 [pmc-release]
AID - diagnostics14050560 [pii]
AID - diagnostics-14-00560 [pii]
AID - 10.3390/diagnostics14050560 [doi]
PST - epublish
SO  - Diagnostics (Basel). 2024 Mar 6;14(5):560. doi: 10.3390/diagnostics14050560.